Official Title
Feasibility of ENGAGE to Address Social Isolation Related to the COVID-19 Pandemic
Brief Summary

This is a single-arm community-based feasibility study examining recruitment, retention,adherence, and satisfaction with ENGAGE, a community-based intervention designed toaddress pandemic-related social isolation among people with disabilities. We will alsoexamine preliminary, within-group effects on social participation. The findings of thisstudy will inform a larger trial to examine intervention efficacy.

Detailed Description

Social isolation has been shown to negatively affect physical and mental health,
particularly among people with disabilities. Social isolation among people with
disabilities has been exacerbated by the COVID-19 pandemic. Even now, people with
disabilities remain hesitant to return to social and community activities due to ongoing
risk of severe cases and death. Yet, we do not have strong models of intervention
designed to address this problem.

ENGAGE is an intervention that may address this gap. ENGAGE was designed to address
social and community participation among people with stroke. We have since conducted
qualitative research to inform adaptation of ENGAGE to meet the needs of a broader range
of people with disabilities related to participation in the context of the ongoing
COVID-19 pandemic. This study is the next step in testing and refining the adapted
intervention protocol. At the end of this study, we will have a finalized adapted
intervention protocol ready for large-scale efficacy testing.

Recruiting
Disabilities Multiple

Behavioral: ENGAGE

ENGAGE is a group intervention designed to improve social participation within the
context of the COVID-19 pandemic.

Eligibility Criteria

Inclusion Criteria:

- Self-identify as disabled

- Report problems with social participation

- Speak English

- Live in a community setting

Exclusion Criteria:

- Severe communication impairment limiting ability to verbally indicate interest in
participation

Eligibility Gender
All
Eligibility Age
Minimum: 18 Years ~ Maximum: N/A
Countries
United States
Locations

University of Illinois Chicago
Chicago, Illinois, United States

Investigator: Joy Hammel, PhD
Contact: 312-996-3513
hammel@uic.edu

Investigator: Jessica Kersey, PhD

Contacts

Joy Hammel, PhD
(312) 996-3513
hammel@uic.edu

Jessica Kersey, PhD
jmkersey@uic.edu

Joy Hammel, PhD, Principal Investigator
University of Illinois Chicago

National Center for Advancing Translational Sciences (NCATS)
NCT Number